3 Top Long-Term Stocks Outperforming Nvidiaby Mark Eisenberg 08.04.2024Nvidia performed well but faces uncertainty as it relies on continuous product sales. However, the growth of cloud computing will ...
Can I Retire on Social Security Alone with Maximum Benefits?by Mark Eisenberg 08.04.2024As of January 2024, the average Social Security recipient collects $1,907 per month. However, those eligible for the maximum benefit ...
Buyers Avoiding Teslas Due To Elon Musk’s Toxic Behaviorby Lilu Anderson 08.04.2024Elon Musk's self-sabotaging behavior is dragging Tesla's reputation down at the worst possible time, but he insists it doesn't affect ...
Twilio Adds Andy Stafman to Boardby Lilu Anderson 08.04.2024Twilio expands its board by adding Andy Stafman, increasing it to 10 members. Sachem Head's stake undisclosed, valued at $11B. ...
Enbridge: A High-Yield Dividend Stock for Long-Term Growthby Mark Eisenberg 08.04.2024Enbridge has been a strong investment over the years, and its acquisition of an Ohio-based gas utility company strengthens its ...
7 Best South Korean Movies Ranked: From Psychological Thrillers to Historical Dramasby Lilu Anderson 07.04.2024"Burning (2018) to The Handmaiden (2016), here are some must-watch Korean psychological thrillers. The Handmaiden stands out with its 1930s ...
Inter vs Empoli Live Stream: Can You Watch for Free?by Lilu Anderson 07.04.2024There are several free live streaming options available for football matches like Lazio vs Juventus, Rangers vs Celtic, UConn vs ...
OpenAI’s Voice Cloning Tool Too Risky: ChatGPT Founderby Lilu Anderson 06.04.2024OpenAI has developed a tool called Voice Engine that can replicate a person's voice from a 15-second audio sample. However, ...
Top 5 AI Resume Builders in 2024: A Guideby Lilu Anderson 06.04.2024A generative AI tool for resume building adds value, but it cannot guarantee effective self-promotion. It enhances existing skills and ...
Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Holdby Terry Bingman 06.04.2024Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...